These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11806257)

  • 1. [An extensive English study: reduced cardiovascular mortality and morbidity by statin].
    Nilsson P; Erhardt L
    Lakartidningen; 2001 Dec; 98(51-52):5846-50. PubMed ID: 11806257
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heart Protection Study].
    Larsen ML; Hildebrandt PR
    Ugeskr Laeger; 2002 Jan; 164(3):348. PubMed ID: 11816337
    [No Abstract]   [Full Text] [Related]  

  • 3. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A too optimistic report of a new study on statins].
    Ravnskov U
    Lakartidningen; 2002 Feb; 99(9):949-51. PubMed ID: 11962023
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M
    MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost effectiveness in the Danish health care of ezetemibe co-administration compared to simvastatin].
    Keiding H; Hildebrandt P; Alemao E; Davies GM
    Ugeskr Laeger; 2008 Jun; 170(26-32):2323-6. PubMed ID: 18570764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statin plus niacin or ezetimibe? What combination for which patients?].
    Parhofer K
    MMW Fortschr Med; 2009 Dec; 151(49-50):16. PubMed ID: 20085070
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholesterol resorption inhibition prevents high statin doses. Lipid lowering in double-pack].
    MMW Fortschr Med; 2002 Nov; 144(48):60. PubMed ID: 12532550
    [No Abstract]   [Full Text] [Related]  

  • 9. [Better with lower LDL cholesterol! Aim at 2 mmol/l for secondary prevention].
    Olsson AG
    Lakartidningen; 2006 Jan 11-17; 103(1-2):22-3. PubMed ID: 16465841
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 12. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of gender on statin efficacy.
    Dale KM; Coleman CI; Shah SA; Patel AA; Kluger J; White CM
    Curr Med Res Opin; 2007 Mar; 23(3):565-74. PubMed ID: 17355737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should women with normal cholesterol be taking a statin? A major study suggests that statins also quell inflammation. Now what?
    Harv Womens Health Watch; 2009 Feb; 16(6):1-3. PubMed ID: 19297742
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).
    Farmer JA
    Curr Atheroscler Rep; 2009 Mar; 11(2):82-3. PubMed ID: 19228479
    [No Abstract]   [Full Text] [Related]  

  • 16. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients].
    Nilsson PM; Attvall S; Båvenholm P
    Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Few patients with coronary diseases are receiving lipid-lowering therapy].
    Stagmo M; Hofman-Bang C; Erhardt L; Rydén L
    Lakartidningen; 2002 Apr; 99(16):1798-9, 1802-3. PubMed ID: 12043479
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins and costs of prevented death cases].
    Robberstad T
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4131. PubMed ID: 9441454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.